Global Patient Registry Software Industry

Global Patient Registry Software Market to Reach US$2. 1 Billion by the Year 2027. Amid the COVID-19 crisis, the global market for Patient Registry Software estimated at US$990 Million in the year 2020, is projected to reach a revised size of US$2.

New York, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Patient Registry Software Industry" - https://www.reportlinker.com/p05957648/?utm_source=GNW
1 Billion by 2027, growing at a CAGR of 11.3% over the analysis period 2020-2027.Product Registries, one of the segments analyzed in the report, is projected to grow at a 10.6% CAGR to reach US$565.8 Million by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Health Service Registries segment is readjusted to a revised 10.8% CAGR for the next 7-year period. This segment currently accounts for a 17.1% share of the global Patient Registry Software market.

The U.S. Accounts for Over 29.5% of Global Market Size in 2020, While China is Forecast to Grow at a 10.9% CAGR for the Period of 2020-2027

The Patient Registry Software market in the U.S. is estimated at US$291.9 Million in the year 2020. The country currently accounts for a 29.48% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$368.4 Million in the year 2027 trailing a CAGR of 10.9% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.9% and 9.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR while Rest of European market (as defined in the study) will reach US$368.4 Million by the year 2027.

Disease Registries Segment Corners a 54.6% Share in 2020

In the global Disease Registries segment, USA, Canada, Japan, China and Europe will drive the 11.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$433.1 Million in the year 2020 will reach a projected size of US$937.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$248 Million by the year 2027.We bring years of research experience to this 6th edition of our report. The 183-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

• Dacima Software, Inc.

• Evado Pty. Ltd.

• FIGmd, Inc.

• Global Vision Technologies, Inc.

• Ifa Systems AG

• Imagetrend, Inc.

• Liaison Technologies

• M2S, Inc.

• McKesson Corporation

• Optum, Inc.

• Velos, Inc.

Read the full report: https://www.reportlinker.com/p05957648/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Global Competitor Market Shares
Patient Registry Software Competitor Market Share Scenario
Worldwide (in %): 2018E

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Patient Registry
Software by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2018 through
2027

Table 2: World Historic Review for Patient Registry Software by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2017

Table 3: World 15-Year Perspective for Patient Registry
Software by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2012, 2018 & 2027

Table 4: World Current & Future Analysis for Product Registries
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2018 through 2027

Table 5: World Historic Review for Product Registries by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2017

Table 6: World 15-Year Perspective for Product Registries by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2018 & 2027

Table 7: World Current & Future Analysis for Health Service
Registries by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2018 through
2027

Table 8: World Historic Review for Health Service Registries by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2017

Table 9: World 15-Year Perspective for Health Service
Registries by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2018 & 2027

Table 10: World Current & Future Analysis for Disease
Registries by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2018 through
2027

Table 11: World Historic Review for Disease Registries by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2017

Table 12: World 15-Year Perspective for Disease Registries by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2018 & 2027

Table 13: World Current & Future Analysis for Hospitals &
Medical Practices by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2018 through 2027

Table 14: World Historic Review for Hospitals & Medical
Practices by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 15: World 15-Year Perspective for Hospitals & Medical
Practices by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2018 & 2027

Table 16: World Current & Future Analysis for Research Centers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2018 through 2027

Table 17: World Historic Review for Research Centers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2017

Table 18: World 15-Year Perspective for Research Centers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2018 & 2027

Table 19: World Current & Future Analysis for Pharma, Biotech &
Medical Device Companies by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2018 through 2027

Table 20: World Historic Review for Pharma, Biotech & Medical
Device Companies by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 21: World 15-Year Perspective for Pharma, Biotech &
Medical Device Companies by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2018 & 2027

Table 22: World Current & Future Analysis for Government
Organizations & TPAs by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2018 through 2027

Table 23: World Historic Review for Government Organizations &
TPAs by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2017

Table 24: World 15-Year Perspective for Government
Organizations & TPAs by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2018 & 2027

Table 25: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2018 through 2027

Table 26: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2017

Table 27: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2018 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Patient Registry Software Market Share (in %) by Company:
2018 & 2027
Market Analytics
Table 28: USA Current & Future Analysis for Patient Registry
Software by Registry Type - Product Registries, Health Service
Registries and Disease Registries - Independent Analysis of
Annual Sales in US$ Million for the Years 2018 through 2027

Table 29: USA Historic Review for Patient Registry Software by
Registry Type - Product Registries, Health Service Registries
and Disease Registries Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2017

Table 30: USA 15-Year Perspective for Patient Registry Software
by Registry Type - Percentage Breakdown of Value Sales for
Product Registries, Health Service Registries and Disease
Registries for the Years 2012, 2018 & 2027

Table 31: USA Current & Future Analysis for Patient Registry
Software by End-Use - Hospitals & Medical Practices, Research
Centers, Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses - Independent Analysis
of Annual Sales in US$ Million for the Years 2018 through 2027

Table 32: USA Historic Review for Patient Registry Software by
End-Use - Hospitals & Medical Practices, Research Centers,
Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 33: USA 15-Year Perspective for Patient Registry Software
by End-Use - Percentage Breakdown of Value Sales for Hospitals &
Medical Practices, Research Centers, Pharma, Biotech &
Medical Device Companies, Government Organizations & TPAs and
Other End-Uses for the Years 2012, 2018 & 2027

CANADA
Table 34: Canada Current & Future Analysis for Patient Registry
Software by Registry Type - Product Registries, Health Service
Registries and Disease Registries - Independent Analysis of
Annual Sales in US$ Million for the Years 2018 through 2027

Table 35: Canada Historic Review for Patient Registry Software
by Registry Type - Product Registries, Health Service
Registries and Disease Registries Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 36: Canada 15-Year Perspective for Patient Registry
Software by Registry Type - Percentage Breakdown of Value Sales
for Product Registries, Health Service Registries and Disease
Registries for the Years 2012, 2018 & 2027

Table 37: Canada Current & Future Analysis for Patient Registry
Software by End-Use - Hospitals & Medical Practices, Research
Centers, Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses - Independent Analysis
of Annual Sales in US$ Million for the Years 2018 through 2027

Table 38: Canada Historic Review for Patient Registry Software
by End-Use - Hospitals & Medical Practices, Research Centers,
Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 39: Canada 15-Year Perspective for Patient Registry
Software by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Medical Practices, Research Centers, Pharma,
Biotech & Medical Device Companies, Government Organizations &
TPAs and Other End-Uses for the Years 2012, 2018 & 2027

JAPAN
Table 40: Japan Current & Future Analysis for Patient Registry
Software by Registry Type - Product Registries, Health Service
Registries and Disease Registries - Independent Analysis of
Annual Sales in US$ Million for the Years 2018 through 2027

Table 41: Japan Historic Review for Patient Registry Software
by Registry Type - Product Registries, Health Service
Registries and Disease Registries Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 42: Japan 15-Year Perspective for Patient Registry
Software by Registry Type - Percentage Breakdown of Value Sales
for Product Registries, Health Service Registries and Disease
Registries for the Years 2012, 2018 & 2027

Table 43: Japan Current & Future Analysis for Patient Registry
Software by End-Use - Hospitals & Medical Practices, Research
Centers, Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses - Independent Analysis
of Annual Sales in US$ Million for the Years 2018 through 2027

Table 44: Japan Historic Review for Patient Registry Software
by End-Use - Hospitals & Medical Practices, Research Centers,
Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 45: Japan 15-Year Perspective for Patient Registry
Software by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Medical Practices, Research Centers, Pharma,
Biotech & Medical Device Companies, Government Organizations &
TPAs and Other End-Uses for the Years 2012, 2018 & 2027

CHINA
Table 46: China Current & Future Analysis for Patient Registry
Software by Registry Type - Product Registries, Health Service
Registries and Disease Registries - Independent Analysis of
Annual Sales in US$ Million for the Years 2018 through 2027

Table 47: China Historic Review for Patient Registry Software
by Registry Type - Product Registries, Health Service
Registries and Disease Registries Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 48: China 15-Year Perspective for Patient Registry
Software by Registry Type - Percentage Breakdown of Value Sales
for Product Registries, Health Service Registries and Disease
Registries for the Years 2012, 2018 & 2027

Table 49: China Current & Future Analysis for Patient Registry
Software by End-Use - Hospitals & Medical Practices, Research
Centers, Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses - Independent Analysis
of Annual Sales in US$ Million for the Years 2018 through 2027

Table 50: China Historic Review for Patient Registry Software
by End-Use - Hospitals & Medical Practices, Research Centers,
Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 51: China 15-Year Perspective for Patient Registry
Software by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Medical Practices, Research Centers, Pharma,
Biotech & Medical Device Companies, Government Organizations &
TPAs and Other End-Uses for the Years 2012, 2018 & 2027

EUROPE
Market Facts & Figures
European Patient Registry Software Market: Competitor Market
Share Scenario (in %) for 2018 & 2027
Market Analytics
Table 52: Europe Current & Future Analysis for Patient Registry
Software by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2018 through 2027

Table 53: Europe Historic Review for Patient Registry Software
by Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2017

Table 54: Europe 15-Year Perspective for Patient Registry
Software by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2012, 2018 & 2027

Table 55: Europe Current & Future Analysis for Patient Registry
Software by Registry Type - Product Registries, Health Service
Registries and Disease Registries - Independent Analysis of
Annual Sales in US$ Million for the Years 2018 through 2027

Table 56: Europe Historic Review for Patient Registry Software
by Registry Type - Product Registries, Health Service
Registries and Disease Registries Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 57: Europe 15-Year Perspective for Patient Registry
Software by Registry Type - Percentage Breakdown of Value Sales
for Product Registries, Health Service Registries and Disease
Registries for the Years 2012, 2018 & 2027

Table 58: Europe Current & Future Analysis for Patient Registry
Software by End-Use - Hospitals & Medical Practices, Research
Centers, Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses - Independent Analysis
of Annual Sales in US$ Million for the Years 2018 through 2027

Table 59: Europe Historic Review for Patient Registry Software
by End-Use - Hospitals & Medical Practices, Research Centers,
Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 60: Europe 15-Year Perspective for Patient Registry
Software by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Medical Practices, Research Centers, Pharma,
Biotech & Medical Device Companies, Government Organizations &
TPAs and Other End-Uses for the Years 2012, 2018 & 2027

FRANCE
Table 61: France Current & Future Analysis for Patient Registry
Software by Registry Type - Product Registries, Health Service
Registries and Disease Registries - Independent Analysis of
Annual Sales in US$ Million for the Years 2018 through 2027

Table 62: France Historic Review for Patient Registry Software
by Registry Type - Product Registries, Health Service
Registries and Disease Registries Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 63: France 15-Year Perspective for Patient Registry
Software by Registry Type - Percentage Breakdown of Value Sales
for Product Registries, Health Service Registries and Disease
Registries for the Years 2012, 2018 & 2027

Table 64: France Current & Future Analysis for Patient Registry
Software by End-Use - Hospitals & Medical Practices, Research
Centers, Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses - Independent Analysis
of Annual Sales in US$ Million for the Years 2018 through 2027

Table 65: France Historic Review for Patient Registry Software
by End-Use - Hospitals & Medical Practices, Research Centers,
Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 66: France 15-Year Perspective for Patient Registry
Software by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Medical Practices, Research Centers, Pharma,
Biotech & Medical Device Companies, Government Organizations &
TPAs and Other End-Uses for the Years 2012, 2018 & 2027

GERMANY
Table 67: Germany Current & Future Analysis for Patient
Registry Software by Registry Type - Product Registries, Health
Service Registries and Disease Registries - Independent
Analysis of Annual Sales in US$ Million for the Years 2018
through 2027

Table 68: Germany Historic Review for Patient Registry Software
by Registry Type - Product Registries, Health Service
Registries and Disease Registries Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 69: Germany 15-Year Perspective for Patient Registry
Software by Registry Type - Percentage Breakdown of Value Sales
for Product Registries, Health Service Registries and Disease
Registries for the Years 2012, 2018 & 2027

Table 70: Germany Current & Future Analysis for Patient
Registry Software by End-Use - Hospitals & Medical Practices,
Research Centers, Pharma, Biotech & Medical Device Companies,
Government Organizations & TPAs and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 71: Germany Historic Review for Patient Registry Software
by End-Use - Hospitals & Medical Practices, Research Centers,
Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 72: Germany 15-Year Perspective for Patient Registry
Software by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Medical Practices, Research Centers, Pharma,
Biotech & Medical Device Companies, Government Organizations &
TPAs and Other End-Uses for the Years 2012, 2018 & 2027

ITALY
Table 73: Italy Current & Future Analysis for Patient Registry
Software by Registry Type - Product Registries, Health Service
Registries and Disease Registries - Independent Analysis of
Annual Sales in US$ Million for the Years 2018 through 2027

Table 74: Italy Historic Review for Patient Registry Software
by Registry Type - Product Registries, Health Service
Registries and Disease Registries Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 75: Italy 15-Year Perspective for Patient Registry
Software by Registry Type - Percentage Breakdown of Value Sales
for Product Registries, Health Service Registries and Disease
Registries for the Years 2012, 2018 & 2027

Table 76: Italy Current & Future Analysis for Patient Registry
Software by End-Use - Hospitals & Medical Practices, Research
Centers, Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses - Independent Analysis
of Annual Sales in US$ Million for the Years 2018 through 2027

Table 77: Italy Historic Review for Patient Registry Software
by End-Use - Hospitals & Medical Practices, Research Centers,
Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 78: Italy 15-Year Perspective for Patient Registry
Software by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Medical Practices, Research Centers, Pharma,
Biotech & Medical Device Companies, Government Organizations &
TPAs and Other End-Uses for the Years 2012, 2018 & 2027

UNITED KINGDOM
Table 79: UK Current & Future Analysis for Patient Registry
Software by Registry Type - Product Registries, Health Service
Registries and Disease Registries - Independent Analysis of
Annual Sales in US$ Million for the Years 2018 through 2027

Table 80: UK Historic Review for Patient Registry Software by
Registry Type - Product Registries, Health Service Registries
and Disease Registries Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2017

Table 81: UK 15-Year Perspective for Patient Registry Software
by Registry Type - Percentage Breakdown of Value Sales for
Product Registries, Health Service Registries and Disease
Registries for the Years 2012, 2018 & 2027

Table 82: UK Current & Future Analysis for Patient Registry
Software by End-Use - Hospitals & Medical Practices, Research
Centers, Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses - Independent Analysis
of Annual Sales in US$ Million for the Years 2018 through 2027

Table 83: UK Historic Review for Patient Registry Software by
End-Use - Hospitals & Medical Practices, Research Centers,
Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 84: UK 15-Year Perspective for Patient Registry Software
by End-Use - Percentage Breakdown of Value Sales for Hospitals &
Medical Practices, Research Centers, Pharma, Biotech &
Medical Device Companies, Government Organizations & TPAs and
Other End-Uses for the Years 2012, 2018 & 2027

REST OF EUROPE
Table 85: Rest of Europe Current & Future Analysis for Patient
Registry Software by Registry Type - Product Registries, Health
Service Registries and Disease Registries - Independent
Analysis of Annual Sales in US$ Million for the Years 2018
through 2027

Table 86: Rest of Europe Historic Review for Patient Registry
Software by Registry Type - Product Registries, Health Service
Registries and Disease Registries Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 87: Rest of Europe 15-Year Perspective for Patient
Registry Software by Registry Type - Percentage Breakdown of
Value Sales for Product Registries, Health Service Registries
and Disease Registries for the Years 2012, 2018 & 2027

Table 88: Rest of Europe Current & Future Analysis for Patient
Registry Software by End-Use - Hospitals & Medical Practices,
Research Centers, Pharma, Biotech & Medical Device Companies,
Government Organizations & TPAs and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 89: Rest of Europe Historic Review for Patient Registry
Software by End-Use - Hospitals & Medical Practices, Research
Centers, Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 90: Rest of Europe 15-Year Perspective for Patient
Registry Software by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Medical Practices, Research Centers,
Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses for the Years 2012,
2018 & 2027

ASIA-PACIFIC
Table 91: Asia-Pacific Current & Future Analysis for Patient
Registry Software by Registry Type - Product Registries, Health
Service Registries and Disease Registries - Independent
Analysis of Annual Sales in US$ Million for the Years 2018
through 2027

Table 92: Asia-Pacific Historic Review for Patient Registry
Software by Registry Type - Product Registries, Health Service
Registries and Disease Registries Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 93: Asia-Pacific 15-Year Perspective for Patient Registry
Software by Registry Type - Percentage Breakdown of Value Sales
for Product Registries, Health Service Registries and Disease
Registries for the Years 2012, 2018 & 2027

Table 94: Asia-Pacific Current & Future Analysis for Patient
Registry Software by End-Use - Hospitals & Medical Practices,
Research Centers, Pharma, Biotech & Medical Device Companies,
Government Organizations & TPAs and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 95: Asia-Pacific Historic Review for Patient Registry
Software by End-Use - Hospitals & Medical Practices, Research
Centers, Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 96: Asia-Pacific 15-Year Perspective for Patient Registry
Software by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Medical Practices, Research Centers, Pharma,
Biotech & Medical Device Companies, Government Organizations &
TPAs and Other End-Uses for the Years 2012, 2018 & 2027

REST OF WORLD
Table 97: Rest of World Current & Future Analysis for Patient
Registry Software by Registry Type - Product Registries, Health
Service Registries and Disease Registries - Independent
Analysis of Annual Sales in US$ Million for the Years 2018
through 2027

Table 98: Rest of World Historic Review for Patient Registry
Software by Registry Type - Product Registries, Health Service
Registries and Disease Registries Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 99: Rest of World 15-Year Perspective for Patient
Registry Software by Registry Type - Percentage Breakdown of
Value Sales for Product Registries, Health Service Registries
and Disease Registries for the Years 2012, 2018 & 2027

Table 100: Rest of World Current & Future Analysis for Patient
Registry Software by End-Use - Hospitals & Medical Practices,
Research Centers, Pharma, Biotech & Medical Device Companies,
Government Organizations & TPAs and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 101: Rest of World Historic Review for Patient Registry
Software by End-Use - Hospitals & Medical Practices, Research
Centers, Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 102: Rest of World 15-Year Perspective for Patient
Registry Software by End-Use - Percentage Breakdown of Value
Sales for Hospitals & Medical Practices, Research Centers,
Pharma, Biotech & Medical Device Companies, Government
Organizations & TPAs and Other End-Uses for the Years 2012,
2018 & 2027

IV. COMPETITION
Total Companies Profiled: 36
Read the full report: https://www.reportlinker.com/p05957648/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001